AiCure and The IMA Group Partner to Optimize Clinical Trial Recruitment and Patient Engagement
IMA Clinical Research, a division of The IMA Group, will equip patients with AiCure s patient engagement solution to observe health management in a non-trial setting, advancing future trial recruitment criteria
News provided by
Share this article
NEW YORK, March 15, 2021 /PRNewswire/
AiCure, an AI and data analytics company focused on improving clinical trials, and IMA, a national leader in providing clinical evaluation and research services, today announced a partnership to gain a widespread understanding of patient behavior and drug compliance outside of a clinical trial setting. With a database of over 300,000 potential subjects, IMA will roll out AiCure s patient engagement solution, Patient Connect, to study participants, offering patients convenient and enhanced support to successfully manage their existing treatment at home. This data will ultimately give sponsors access to a
Share
IMA Clinical Research, a division of the IMA Group that provides clinical evaluation and research services, has partnered with
AiCure to deploy the patient engagement company s Patient Connect tool to patients in a new effort to observe health management beyond the traditional study setting.
The 30-day program will have participants using the smartphone app to confirm adherent dosing behavior and stay in contact with a clinician in case they need additional support, all while the app collects digital biomarker data to monitor their condition. With these data, the partners say that they will be able to provide future study sponsors with a well-described cohort of patients across a range of therapeutic areas.